跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CAR-T cell therapy (solid tumor)
首页
药物
CAR-T cell therapy (solid tumor)
CAR-T cell therapy (solid tumor)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHOD TO GENERATE IMPROVING CAR-T CELLS
EP 4598565 A1
申请人: INST NAT SANTE RECH MED
优先权: 2022
EP
US
WO
3 件公开
TREATMENT OF SOLID TUMORS WITH A REGIMEN OF TARGETED RADIONUCLIDE THERAPY AND GENETICALLY ENGINEERED IMMUNE CELL THERAPIES
EP 4727561 A1
申请人: WISCONSIN ALUMNI RES FOUND
优先权: 2023
CN
EP
WO
3 件公开
CAR T CELL THERAPY METHOD
EP 4333811 A4
申请人: UNIV FLORIDA
优先权: 2021
EP
US
2 件公开
NKG2D CAR CELLS EXPRESSING IL-18 FOR ADOPTIVE CELL THERAPY
US 2024366668 A1
申请人: CELYAD ONCOLOGY S A
优先权: 2021
US
2 件公开
Anti-tumor drug combination and application thereof
CN 119971030 A
申请人: NANKAI INTERNATIONAL ADVANCED RES INSTITUTE SHENZHEN FUTIAN
优先权: 2025
CN
2 件公开
Cellular expression of hyaluronidase and application thereof in solid tumor cell therapy
CN 107400664 A
申请人: CAI SHENGHE
优先权: 2016
CN
Specific targeting receptor protein MAGEA and construction method of CAR-T carrier thereof
CN 107446938 A
申请人: ZHAO WEI
优先权: 2016
CN
Bispecific chimeric antigen receptor c-Met/PD-1 scFv-CAR-T, and construction method and application thereof
CN 109422815 A
申请人: UNIV FUDAN
优先权: 2017
CN
Joint use of immunologic effector cells and radiation in tumor treatment
CN 109908176 A
申请人: CARSGEN THERAPEUTICS SHANGHAI CO LTD
优先权: 2017
CN
Reagent for enhancing capacity of homing CAR-T cell to solid tumor tissue
CN 109593726 A
申请人: CHONGQING PREC BIOTECH CO LTD
优先权: 2018
CN
第 1 / 5 页
上一页
下一页
药物
反馈